146 related articles for article (PubMed ID: 2128519)
21. [Psychosine: a "toxin" produced in the brain--its mechanism of action].
Igisu H
J UOEH; 1989 Dec; 11(4):487-93. PubMed ID: 2558407
[TBL] [Abstract][Full Text] [Related]
22. The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease).
Kobayashi T; Yamanaka T; Jacobs JM; Teixeira F; Suzuki K
Brain Res; 1980 Dec; 202(2):479-83. PubMed ID: 7437911
[TBL] [Abstract][Full Text] [Related]
23. L-cycloserine slows the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice).
LeVine SM; Pedchenko TV; Bronshteyn IG; Pinson DM
J Neurosci Res; 2000 Apr; 60(2):231-6. PubMed ID: 10740228
[TBL] [Abstract][Full Text] [Related]
24. Biochemical pathogenesis of genetic leukodystrophies: comparison of metachromatic leukodystrophy and globoid cell leukodystrophy (Krabbe's disease).
Suzuki K
Neuropediatrics; 1984 Sep; 15 Suppl():32-6. PubMed ID: 6152811
[TBL] [Abstract][Full Text] [Related]
25. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice.
Pannuzzo G; Cardile V; Costantino-Ceccarini E; Alvares E; Mazzone D; Perciavalle V
Mol Genet Metab; 2010 Jul; 100(3):234-40. PubMed ID: 20418135
[TBL] [Abstract][Full Text] [Related]
26. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease.
Khan M; Haq E; Giri S; Singh I; Singh AK
J Neurosci Res; 2005 Jun; 80(6):845-54. PubMed ID: 15898099
[TBL] [Abstract][Full Text] [Related]
27. Suppressed UDP-galactose: ceramide galactosyltransferase and myelin protein mRNA in twitcher mouse brain.
Taniike M; Marcus JR; Nishigaki T; Fujita N; Popko B; Suzuki K; Suzuki K
J Neurosci Res; 1998 Feb; 51(4):536-40. PubMed ID: 9514207
[TBL] [Abstract][Full Text] [Related]
28. Cerebroside formation in the peripheral nervous system of normal and Trembler mice.
Boiron-Sargueil F; Heape A; Garbay B; Cassagne C
Neurosci Lett; 1995 Feb; 186(1):21-4. PubMed ID: 7783943
[TBL] [Abstract][Full Text] [Related]
29. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine.
Kobayashi T; Goto I; Yamanaka T; Suzuki Y; Nakano T; Suzuki K
Ann Neurol; 1988 Oct; 24(4):517-22. PubMed ID: 3239954
[TBL] [Abstract][Full Text] [Related]
30. The twitcher mouse: accumulation of galactosylsphingosine and pathology of the central nervous system.
Tanaka K; Nagara H; Kobayashi T; Goto I
Brain Res; 1989 Mar; 482(2):347-50. PubMed ID: 2706492
[TBL] [Abstract][Full Text] [Related]
31. Effects of brefeldin A on galactosphingolipid synthesis in an immortalized Schwann cell line: evidence for different intracellular locations of galactosylceramide sulfotransferase and ceramide galactosyltransferase activities.
Farrer RG; Warden MP; Quarles RH
J Neurochem; 1995 Oct; 65(4):1865-73. PubMed ID: 7561886
[TBL] [Abstract][Full Text] [Related]
32. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.
Kobayashi T; Shinoda H; Goto I; Yamanaka T; Suzuki Y
Biochem Biophys Res Commun; 1987 Apr; 144(1):41-6. PubMed ID: 3579916
[TBL] [Abstract][Full Text] [Related]
33. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.
van der Bijl P; Strous GJ; Lopes-Cardozo M; Thomas-Oates J; van Meer G
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):589-97. PubMed ID: 8713090
[TBL] [Abstract][Full Text] [Related]
35. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
[TBL] [Abstract][Full Text] [Related]
36. Saposins (sap) A and C activate the degradation of galactosylsphingosine.
Harzer K; Hiraiwa M; Paton BC
FEBS Lett; 2001 Nov; 508(1):107-10. PubMed ID: 11707278
[TBL] [Abstract][Full Text] [Related]
37. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis.
Bosio A; Binczek E; Stoffel W
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13280-5. PubMed ID: 8917582
[TBL] [Abstract][Full Text] [Related]
38. Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease.
Teixeira CA; Miranda CO; Sousa VF; Santos TE; Malheiro AR; Solomon M; Maegawa GH; Brites P; Sousa MM
Neurobiol Dis; 2014 Jun; 66():92-103. PubMed ID: 24607884
[TBL] [Abstract][Full Text] [Related]
39. TNF-receptor 1 deficiency fails to alter the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice) but affords protection following LPS challenge.
Pedchenko TV; Bronshteyn IG; LeVine SM
J Neuroimmunol; 2000 Oct; 110(1-2):186-94. PubMed ID: 11024549
[TBL] [Abstract][Full Text] [Related]
40. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis.
Svennerholm L; Vanier MT; Månsson JE
J Lipid Res; 1980 Jan; 21(1):53-64. PubMed ID: 7354254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
